$KAPA

$0.52 +$0.00 (0.0%) After hours

$KAPA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 23.7M shares outstanding

Who owns KAPA?

By type of holder

Institutions 4.0% Insiders 32.1% Everyone else 64.0%

Concentration Top 10 holders own 35.0%

Yu John S 23.4% · Bhowmick Neil 5.5%

Institutional ownership

4.0%

+1.4 pts vs last qtr

Institutional holders

+2 vs last qtr

Net shares bought

+337.6K

by institutions in Q2 2026

New / sold out

6 / 4

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Citadel Advisors LLC NEW +309.8K
Virtu Financial LLC NEW +82.1K

Biggest sellers in Q2 2026

Two Sigma Investments, LP SOLD OUT −39.5K
Geode Capital Management, LLC −32.4K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Kairos Pharma Ltd in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2023–FY2025

+77.5%

+33.22% a year

Each share's claim on the business

−43.7%

shrank without buying or selling a share

Diluted shares, split-adjusted

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years18% Under 1 year82%

Quarterly turnover

46.4%

of institutional shares changed hands

Top 10 managers, median time held

3 quarters

Super Investors

Investment managers reporting KAPA on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
CA Citadel Advisors LLC	309.8K	1.31%	NEW	Q2 '26	0.0%
Shares held by quarter Peak holding321.7K (Q4'25) Change over 8 quarters+309.8K Share of the company1.310% Citadel Advisors LLC's full portfolio →
VC Vanguard Capital Management LLC	231.9K	0.98%	Unchanged	Q3 '25	0.0%
Shares held by quarter Peak holding231.9K (Q1'26) Change over 8 quarters+231.9K Share of the company0.980% Vanguard Capital Management LLC's full portfolio →

Citadel Advisors LLC

309.8K

% of company

1.31%

Change vs last qtr

NEW

Held since

Q2 '26

Vanguard Capital Management LLC

231.9K

% of company

0.98%

Change vs last qtr

Unchanged

Held since

Q3 '25

15 more super investors behind a free account

See every manager holding Kairos Pharma Ltd, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting KAPA on Form N-PORT; together they hold 1.2% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VI Vanguard Institutional Total Stock Market Index Fund Vanguard Institutional Index Funds	$62.9K	163.9K	0.69%	0.00%	June 30, 2026
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$26.1K	67.9K	0.29%	0.00%	June 30, 2026

Vanguard Institutional Total Stock Market Index Fund

Vanguard Institutional Index Funds

Position value

$62.9K

% of company

0.69%

% of the fund

0.00%

As of

June 30, 2026

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$26.1K

% of company

0.29%

% of the fund

0.00%

As of

June 30, 2026

3 more funds behind a free account

See every fund holding Kairos Pharma Ltd and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
YJ Yu John S Insider	5.5M	23.41%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company23.410% Yu John S's insider activity →
BN Bhowmick Neil Insider	1.3M	5.54%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company5.540% Bhowmick Neil's insider activity →

Yu John S

Insider

5.5M

% of company

23.41%

Change vs last qtr

—

Held since

—

Bhowmick Neil

Insider

1.3M

% of company

5.54%

Change vs last qtr

—

Held since

—

5 more holders behind a free account

See every insider and 5%+ holder of Kairos Pharma Ltd.

Comments